Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2005 | 11-2004 | 11-2003 | 11-2002 | 11-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,179 | 4,937 | 2,452 | 1,936 | 5,541 |
| Marketable Securities | 485 | 603 | 798 | 3,128 | 261 |
| Receivables | 1,044 | 1,276 | 679 | 694 | 1,885 |
| Income taxes - deferred | 45 | 141 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 211 | 52 |
| TOTAL | $10,447 | $7,385 | $4,296 | $6,080 | $7,962 |
| Non-Current Assets | |||||
| PPE Net | 2,924 | 2,823 | 1,355 | 2,633 | 3,185 |
| Investments And Advances | 720 | 1,381 | 1,267 | 2,655 | 5,745 |
| Intangibles | 0 | 0 | 0 | 0 | 120 |
| Other Non-Current Assets | 143 | 193 | 300 | 2,049 | 383 |
| TOTAL | $3,787 | $4,397 | $2,922 | $7,336 | $9,432 |
| Total Assets | $14,234 | $11,782 | $7,217 | $13,416 | $17,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 145 | N/A | N/A |
| Accounts payable and accrued liabilities | 479 | 483 | 341 | 391 | 115 |
| Accrued Expenses | 1,172 | 1,337 | 1,638 | 1,217 | 248 |
| TOTAL | $4,928 | $4,591 | $4,232 | $2,819 | $832 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,278 | 2,772 | 2,108 | 1,210 | N/A |
| Other Non-Current Liabilities | 3,750 | 3,750 | 3,750 | 4,417 | 24 |
| TOTAL | $8,911 | $8,026 | $6,777 | $6,891 | $2,041 |
| Total Liabilities | $13,839 | $12,618 | $11,008 | $9,709 | $2,873 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,625 | 11,550 | 11,998 | 11,995 | 11,326 |
| Common Shares | 116 | 114 | 114 | 114 | 113 |
| Retained earnings | -22,376 | -23,409 | -26,249 | -19,031 | -7,931 |
| Other shareholders' equity | -114 | 30 | 49 | -388 | 43 |
| TOTAL | $395 | $-836 | $-3,791 | $3,707 | $14,521 |
| Total Liabilities And Equity | $14,234 | $11,782 | $7,217 | $13,416 | $17,394 |